Yesterday was a great day for Medivation (MDVN) (Aggressive Growth Portfolio) holders.
Medivation announced a very successful test on its prostate cancer drug and the stock promptly doubled (as in up 140%).
I think we have to take some money off the table after an event like this. So at the opening this morning, the Aggressive Growth Portfolio will trim this position back to a normal sized 10 bagger holding (one third to one quarter of a normal holding).
The proceeds will be re-invested in another 10 bagger Polymedix . Symbol PYMX
Steve Cook
Strategic Stock Investments
Subscriber Alert
No comments:
Post a Comment